We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.25 | 17.50 | 19.00 | 18.25 | 18.25 | 18.25 | 144,329 | 07:39:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/7/2019 09:42 | Revenues?? | rastamouse | |
03/7/2019 09:40 | If be surprised and happy IF we hold on to this little gain today. It means my Spreadbets are actually in positive territory, which has been a rarity. Onwards and upwards 😊 John | 2350220 | |
03/7/2019 09:39 | This is a prime example of Opti building & completing supply chains in major territories. 'EIWA will have the exclusive rights to import, market and distribute'. This means they buy from Sacco & produce a product tailored for their client in either food/supplements or dairy. Today's deal will most probably be their customer rather than one Opti have engaged. EIWA are basically a sales team in japan for LPLDL. Whoever they distribute LPLDL to will have to have a license via Opti for the rights to sell a finished product, today is the first example. It's slow but it's ridiculously cost effective because in effect we have a Japanese sales team that have decades of experience in the market. Once all aligned across multiple territories the flow of cash from the licenses rolls in from the major markets in the world & the costs remain static. This is how you build a global brand for peanuts whilst enhancing the revenue & most importantly profit opportunity significantly. | riskybusiness1 | |
03/7/2019 09:27 | The lack of trading volume after all these deals shows that SOH is right to turn his attention to the investor side of things. Hopefully he can get this share price motoring over the summer. As an aside, when is the big alfasigma launch due? I thought that was supposed to be soon back in April. That should generate some decent revenues once up and running. | imnotlong | |
03/7/2019 09:24 | In the last results the revenue growth was gearing up in last few months of that period as was stated by SOH ,so not sure why the comment we know first half numbers are not going to be great. I’m expecting a continuation of that rate of growth and above and if we don’t get it this will drop quite sharply I would suggest | best1467 | |
03/7/2019 08:40 | cant wait LOL | humphries1 | |
03/7/2019 08:31 | Hopefully, the side effect will be making a bit of money ... eventually :) | m4rtinu | |
03/7/2019 08:23 | Ramas- I think you need to do a bit more research, this is science backed and it is peer reviewed. There are no side effects! | primal123 | |
03/7/2019 08:23 | >> ramas LPLDL has GRAS status in the US which means you can eat it in food. Slimbiome has medical device status in Europe which again signifies that there is substantial data to show it is completely safe as a food supplement. Nuff said... | nobbygnome | |
03/7/2019 08:12 | iis and pis still need time to comprehend how a licencing , virtual production model works , just like ARM as it sat at 150p before rocketing to 10000p in short order before then being acquired. There is one risk here and that is that the product doesn't work or damages you so if anyone want to put that case to me I'm interested to listen ....failing that patience needed while the dinosaurs digest the business model. | ramas | |
03/7/2019 08:09 | Smarner Not even worth trying to value Opti as the weekly addition of new deals and products keeps rendering projections out of date. We all know H1 won’t be brilliant but soh has hinted full year numbers will be good and then just keep growing. There’s so much going on that I would hate to not be in here. S | shrewdmole | |
03/7/2019 08:09 | Oh dear, I have a new troll. Sorry guys, buywell3 is another super troll. | nobbygnome | |
03/7/2019 08:06 | Ether way, no harm done to your imaginary short. Turkey. | slartybartfaster | |
03/7/2019 08:06 | I am sure we will see multiple deals coming out of Japan through EIWA. This is just the first. | parob | |
03/7/2019 08:05 | Turnover 0.51 Cash raise coming IMO | buywell3 | |
03/7/2019 08:05 | So you sign a deal in the third biggest market in the world and it adds about £1 million to the market cap. Completely mad.... | nobbygnome | |
03/7/2019 08:02 | Thanks for that list Parob. If Opti keeps adding contracts/agreements like this you're gonna need a toilet roll soon if you want to print it out : )How can anyone think this company isn't going places?Sienna | siennadelekat21 | |
03/7/2019 07:58 | Whitegold As he earlier deals start to come on line after product development the revenues will be growing all the time now. Meanwhile Opti just keep tying up more partners for etch and new strains and products. We’ve still got 2 sbtx deals to be announced, one with a global. Update on sweetbiotix is well over due. Additional seed deal for the expanded countries. Soh interview the other day was a clear indication of the commercial traction they now have. Steve | shrewdmole | |
03/7/2019 07:57 | Over 50 manufacturing & distribution agreements. Conservative estimated average value anyone? | smarner | |
03/7/2019 07:57 | I need to update my list below for Seed Health. They are not just a US LP-LDL distributor, they are now a GLOBAL LP-LDL distributor, shipping to 44 countries. | parob | |
03/7/2019 07:55 | Aye ! 'God' help the anti opti hate mob when the mist does lift and the 'seeds' start hitting continual winners ! lol | reckless kelly | |
03/7/2019 07:53 | Look at that list of contracts Hami. Why not raise a glass and toast our excellent product and sales team. Well done Opti - hats off to the likes of Primal, Elrico etc who put in the miles to keep us updated in the face of much scurillous shorter garbage. Onwards and upwards.GLA. | whitegold1 | |
03/7/2019 07:50 | I was disappointed at the lack of an AGM trading update but look forward to Results soon when the Outlook statement will be of particular significance as I doubt whether any one can estimate with any accuracy our projected current year Revenues , including SOH. Glad to have increased substantially at around 75p a few weeks ago & now in bottom draw until the mist lifts on our potential-which i expect to be substantial | base7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions